London
· Delayed Price · Currency is GBP · Price in USD Tandem Diabetes Care Statistics
Total Valuation
LON:0M0F has a market cap or net worth of GBP 884.25 million. The enterprise value is 914.35 million.
| Market Cap | 884.25M |
| Enterprise Value | 914.35M |
Important Dates
The next estimated earnings date is Friday, May 2, 2025.
| Earnings Date | May 2, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
| Current Share Class | n/a |
| Shares Outstanding | n/a |
| Shares Change (YoY) | +0.74% |
| Shares Change (QoQ) | +0.94% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | 65.95M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 1.18 |
| PB Ratio | 4.21 |
| P/TBV Ratio | 4.22 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -11.92 |
| EV / Sales | 1.29 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | 229.21 |
Financial Position
The company has a current ratio of 2.93, with a Debt / Equity ratio of 1.82.
| Current Ratio | 2.93 |
| Quick Ratio | 2.24 |
| Debt / Equity | 1.82 |
| Debt / EBITDA | n/a |
| Debt / FCF | 95.79 |
| Interest Coverage | -13.37 |
Financial Efficiency
Return on equity (ROE) is -33.30% and return on invested capital (ROIC) is -8.40%.
| Return on Equity (ROE) | -33.30% |
| Return on Assets (ROA) | -6.45% |
| Return on Invested Capital (ROIC) | -8.40% |
| Return on Capital Employed (ROCE) | -13.76% |
| Revenue Per Employee | 283,398 |
| Profits Per Employee | -28,944 |
| Employee Count | 2,650 |
| Asset Turnover | 0.98 |
| Inventory Turnover | 2.93 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -51.14% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | -51.14% |
| 50-Day Moving Average | 21.76 |
| 200-Day Moving Average | 33.78 |
| Relative Strength Index (RSI) | 38.26 |
| Average Volume (20 Days) | 236 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 4.39 |
Income Statement
In the last 12 months, LON:0M0F had revenue of GBP 751.01 million and -76.70 million in losses. Loss per share was -1.17.
| Revenue | 751.01M |
| Gross Profit | 391.06M |
| Operating Income | -79.18M |
| Pretax Income | -73.38M |
| Net Income | -76.70M |
| EBITDA | -65.91M |
| EBIT | -79.18M |
| Loss Per Share | -1.17 |
Balance Sheet
The company has 350.12 million in cash and 382.10 million in debt, giving a net cash position of -31.98 million.
| Cash & Cash Equivalents | 350.12M |
| Total Debt | 382.10M |
| Net Cash | -31.98M |
| Net Cash Per Share | n/a |
| Equity (Book Value) | 210.15M |
| Book Value Per Share | 3.17 |
| Working Capital | 381.37M |
Cash Flow
In the last 12 months, operating cash flow was 19.35 million and capital expenditures -15.36 million, giving a free cash flow of 3.99 million.
| Operating Cash Flow | 19.35M |
| Capital Expenditures | -15.36M |
| Free Cash Flow | 3.99M |
| FCF Per Share | n/a |
Margins
Gross margin is 52.07%, with operating and profit margins of -10.54% and -10.21%.
| Gross Margin | 52.07% |
| Operating Margin | -10.54% |
| Pretax Margin | -9.77% |
| Profit Margin | -10.21% |
| EBITDA Margin | -8.78% |
| EBIT Margin | -10.54% |
| FCF Margin | 0.53% |
Dividends & Yields
LON:0M0F does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -0.74% |
| Shareholder Yield | -0.74% |
| Earnings Yield | -8.67% |
| FCF Yield | 0.45% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
LON:0M0F has an Altman Z-Score of 1.72. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 1.72 |
| Piotroski F-Score | n/a |